BLOOMBERG OPINION
Vaccine news comes ahead of perilous two months
By the end of this month Pfizer and BioNTech are expected to have enough data to apply for emergency use of the vaccine
11 November 2020 - 15:04
Monday brought the most promising news so far in the pharmaceutical fight against Covid-19: a candidate vaccine has prevented more than 90% of symptomatic infections among people who received it in a large clinical trial.
By the end of this month Pfizer and BioNTech are expected to have enough data to apply for emergency use of the vaccine. With luck, it appears that 25-million people could be vaccinated by the end of the year, and during 2021 about 650-million more...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.